SCHOTT PHARMA AG& CO KGAA (1SXP.DE) Stock Earnings & Estimates
FRA:1SXP - DE000A3ENQ51 - Common Stock
23.275 EUR
-0.12 (-0.53%)
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 821.1M 26.58% | 898.602M 9.44% | 957.091M 6.51% | 1.021B 6.68% | 1.121B 9.79% | 1.246B 11.15% | 1.341B 7.62% | 1.437B 7.16% | 2.014B 40.15% | 2.074B 2.98% | |
| EBITDA YoY % growth | 223.5M 47.72% | 217.822M -2.54% | 255.565M 17.33% | 266.95M 4.45% | 316.02M 18.38% | 377.38M 19.42% | 401.27M 6.33% | 437.77M 9.10% | 562.43M 28.48% | 604.82M 7.54% | |
| EBIT YoY % growth | 168.1M 46.30% | 171.174M 1.83% | 190.587M 11.34% | 204.27M 7.18% | 245.5M 20.18% | 285.04M 16.11% | 295.65M 3.72% | 320.8M 8.51% | N/A | N/A | |
| Operating Margin | 20.47% | 19.05% | 19.91% | 20.01% | 21.90% | 22.88% | 22.05% | 22.32% | N/A | N/A | |
| EPS YoY % growth | N/A | N/A | 0.99 4.50% | 1.04 4.64% | 1.21 16.87% | 1.41 16.42% | 1.53 8.26% | 1.64 7.17% | N/A | N/A |
All data in EUR
| Q4 / 25 | Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | |
|---|---|---|---|---|---|
| EPS Q2Q % growth | 0.24 8.49% | 0.26 37.16% | 0.29 12.59% | 0.31 4.55% | 0.29 22.65% |
| Revenue Q2Q % growth | 251.76M 6.20% | 254.67M 10.80% | 276.21M 9.47% | 287.98M 12.29% | 272.94M 8.41% |
| EBITDA Q2Q % growth | 63.068M -42.35% | 71.995M 32.52% | 77.6M -11.12% | 81.504M -30.62% | 75.449M 19.63% |
| EBIT Q2Q % growth | 45.217M 1.81% | 50.635M 41.47% | 55.878M 12.46% | 59.587M -0.89% | 54.463M 20.45% |
All data in EUR
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2025 Q2Q % growth | 0.30 -3.23% | 0.30 | 0.00 | -1.05% |
| Q2 2025 Q2Q % growth | 0.26 52.94% | 0.25 | 0.01 | 5.48% |
| Q1 2025 Q2Q % growth | 0.19 -34.48% | 0.22 | -0.03 | -14.42% |
| Q4 2024 Q2Q % growth | 0.22 -4.35% | 0.25 | -0.03 | -10.99% |
| Q3 2024 Q2Q % growth | 0.31 | 0.21 | 0.10 | 50.83% |
| Q2 2024 Q2Q % growth | 0.17 | 0.21 | -0.04 | -20.63% |
| Q1 2024 Q2Q % growth | 0.29 | 0.28 | 0.01 | 3.11% |
| Q4 2023 Q2Q % growth | 0.23 | 0.16 | 0.07 | 40.93% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2025 Q2Q % growth | 256.46M 1.13% | 262.43M | -5.97M | -2.27% |
| Q2 2025 Q2Q % growth | 252.326M 7.95% | 247.99M | 4.336M | 1.75% |
| Q1 2025 Q2Q % growth | 229.841M -1.04% | 242.74M | -12.899M | -5.31% |
| Q4 2024 Q2Q % growth | 237.051M 3.73% | 244.39M | -7.339M | -3.00% |
| Q3 2024 Q2Q % growth | 253.587M -62.16% | 228.25M | 25.337M | 11.10% |
| Q2 2024 Q2Q % growth | 233.749M | 238.89M | -5.141M | -2.15% |
| Q1 2024 Q2Q % growth | 232.251M | 212M | 20.251M | 9.55% |
| Q4 2023 Q2Q % growth | 228.516M 12.57% | 233.12M | -4.604M | -1.97% |
| Q3 2023 Q2Q % growth | 670.086M 8.41% | % |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | -12.9% | N/A | -0.29% | -0.29% |
| Revenue | -6.07% | N/A | -1.73% | -1.73% |